To identify the association between differential expression of exosomal PD-L1 or PD-1 and tumor response, the variation in the expression of exoPD-L1/PD-1 extracted from the serum of NSCLC patients before and after immunotherapy was assessed. This evidence concerns the gene CD274 and neoplasm.